Connect with us

Hi, what are you looking for?

Jewish Business News

Leadership & A-List

New Oracle Co-CEO Safra Catz Won’t Tolerate Second Place


Oracle CEO Larry Ellison Addresses Oracle's OpenWorld 2010 Conference

After the departure of Oracle founder and CEO Larry Ellison, Oracle co-CEO Safra Catz (who with co-CEO Mark Hurd, makes the management team a challenge, tantamount to  Hurd & Catz) says the company will not tolerate “silver medals” or second place, reports Seeking Alpha.

Israeli-born Safra Catz said, “We’re No.1 in database, we’re No 1. in middleware, but we’re No.2 in applications. At Oracle, silver medal is first loser.” Not only has Oracle, which was the leading player for years, to contend with in the cloud, but Catz’s statements come as competitor SAP made a deal to pay $8.3 billion for Concur Technologies, a software vendor which manages expenses through cloud technology.

Oracle has also been facing weakness in software licensing growth and slowing database sales. Oracle, like other companies, has been buying up smaller companies to win, a strategy perfected under Ellison’s leadership, but its opponents are applying the same strategy and giving Oracle a run for its money. Among the long list of acquisitions is a hardware/software firm Micros, for which Oracle shelled out $5.8 billion. Aside from other things Oracle has to show for the purchase is an addition to its onerous debt, amounting to $32.6 billion.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...


The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.

cialis cialis satış